Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients - FINE Trial.
Demır GA, Türkoğlu R, Saıp S, Yüceyar N, Efendı H, Turan ÖF, Ağan K, Terzı M, Boz C, Tuncer A, Koçer B, Kasap M, Çalişkan Z; Fine Study Group. Demır GA, et al. Among authors: yuceyar n. Noro Psikiyatr Ars. 2017 Jun 22;56(4):253-257. doi: 10.5152/npa.2017.20515. eCollection 2019 Dec. Noro Psikiyatr Ars. 2017. PMID: 31903032 Free PMC article.
Overactive bladder symptoms in patients with multiple sclerosis: Frequency, severity, diagnosis and treatment.
Akkoç Y, Ersöz M, Yüceyar N, Tunç H, Köklü K, Yoldaş TK, Dönmez Ü, Uzunköprü C, Alemdaroğlu E, Bilen Ş, Emre U, Özdolap Ş, Tuncay E, Yücesan C, Gök H, Ercan MB, Uygunol K, Koçer B, Zinnuroğlu M; Neurogenic Bladder Turkish Research Group. Akkoç Y, et al. Among authors: yuceyar n. J Spinal Cord Med. 2016;39(2):229-33. doi: 10.1179/2045772315Y.0000000021. Epub 2016 Feb 15. J Spinal Cord Med. 2016. PMID: 25936385 Free PMC article.
Comparative analysis of fingolimod versus teriflunomide in relapsing-remitting multiple sclerosis.
Boz C, Terzi M, Özer B, Turkoglu R, Karabudak R, Efendi H, Soysal A, Sevim S, Altintas A, Kurne A, Akçalı A, Akman G, Yüceyar N, Balcı BP, Ekmekci Ö, Karahan SZ, Demirkıran M, Altunrende B, Turan ÖF, Gökçen GözübatıkÇelik, Kale N, Köseoğlu M, Ozakbas S. Boz C, et al. Among authors: yuceyar n. Mult Scler Relat Disord. 2019 Nov;36:101376. doi: 10.1016/j.msard.2019.101376. Epub 2019 Aug 26. Mult Scler Relat Disord. 2019. PMID: 31473488
'Is RLS a harbinger and consequence of MS?: Striking results of the 'RELOMS-T' study'.
Sevim S, Demirkıran M, Terzi M, Yüceyar N, Taşdelen B, İdiman E, Kürtüncü M, Boz C, Tuncel D, Karabudak R, Siva A, Özcan A, Neyal M, Göksel BK, Balal M, Şen S, Ekmekçi Ö, Öksüz N, Kaya D. Sevim S, et al. Among authors: yuceyar n. Mult Scler Relat Disord. 2020 Jul;42:102055. doi: 10.1016/j.msard.2020.102055. Epub 2020 Mar 16. Mult Scler Relat Disord. 2020. PMID: 32473575
Coexistence of restless legs syndrome and multiple sclerosis aggravates anxiety and depression.
Sevim S, Demirkiran M, Terzi M, Yüceyar N, Taşdelen B, Idiman E, Kürtüncü M, Boz C, Tuncel D, Karabudak R, Siva A, Özcan A, Neyal M, Göksel BK, Gazaloğlu GB, Balal M, Şen S, Baklan MA, Gündüz T, Tuncer A, Uygunoğlu U. Sevim S, et al. Among authors: yuceyar n. Arq Neuropsiquiatr. 2022 Feb;80(2):168-172. doi: 10.1590/0004-282X-ANP-2020-0400. Arq Neuropsiquiatr. 2022. PMID: 35195221 Free PMC article.
The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?
Sen S, Tuncer A, Ozakbas S, Uzunkopru C, Baba C, Demir S, Beckmann Y, Gumus H, Arslan G, Kilic AK, Altintas A, Yuceyar N, Turan OF, Tutuncu M, Terzi M, Acar P, Bunul SD, Balci BP, Bir LS, Koseoglu M, Mungan S, Gunduz T, Dogan IG, Kotan D, Uygunoglu U, Ekmekci O, Demirkiran M, Kamisli O, Kabay SC, Tamam Y, Omerhoca S, Sevim S, Guler S, Kurtuncu M, Efendi H, Karabudak R, Siva A. Sen S, et al. Among authors: yuceyar n. Mult Scler Relat Disord. 2022 Feb;58:103399. doi: 10.1016/j.msard.2021.103399. Epub 2021 Nov 19. Mult Scler Relat Disord. 2022. PMID: 35216782 Free PMC article.
The comparative effectiveness of fingolimod, natalizumab, and ocrelizumab in relapsing-remitting multiple sclerosis.
Boz C, Ozakbas S, Terzi M, Karabudak R, Sevim S, Turkoglu R, Soysal A, Balcı BP, Efendi H, Turan ÖF, Yüceyar N, Yetkin MF, Karahan SZ, Demirkıran M, Guler S, Agan K, Kıylıoğlu N, Baba C, Tuncer A, Köseoğlu M. Boz C, et al. Among authors: yuceyar n. Neurol Sci. 2023 Jun;44(6):2121-2129. doi: 10.1007/s10072-023-06608-z. Epub 2023 Jan 23. Neurol Sci. 2023. PMID: 36689010
54 results